← Leaderboards
Victor A Raso
Boston Biomedical Research Institute
$5,768,937
Attributed
$5,768,937
Total exposure
15
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $542.3K · FY2005–10$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$5,768,937 · 15
By mechanism
R44$2,666,787 · 3
R01$1,958,050 · 1
P51$471,100 · 8
R21$470,000 · 2
R03$203,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Immunotherapy”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,653,178
- Constance Ann Benson · University Of California, San Diego$150,079,712
- Joseph Sparano · Montefiore Medical Center (Bronx, Ny)$111,361,061
- Robert H Vonderheide · University Of Pennsylvania$84,159,371
- Sharon A Nachman · Johns Hopkins University$74,725,055
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
Research focus
ImmunotherapyLaboratory MouseAlzheimer'S DiseaseGenetically Modified AnimalsAmyloid ProteinsNeuritic PlaquesVaccinesNonhuman Therapy EvaluationAntigen Antibody ReactionMonoclonal AntibodyVaccine DevelopmentGhrelinSynthetic PeptidePassive ImmunizationHybrid AntibodyAge DifferenceActive ImmunizationFundingSourceBaseResourcesInstitutionComputer Retrieval Of Information On Scientific Projects DatabaseGrant
Grant awards (29)
TESTING GHRELIN AND PYY VACCINES$65,759
P51 · FY2010 · RR · contact PI
Insulin-like Growth Factor 1 Vaccine for Cancer Prevention$101,500
R03 · FY2009 · CA · contact PI
TESTING GHRELIN AND PYY VACCINES$64,877
P51 · FY2009 · RR · contact PI
Insulin-like Growth Factor 1 Vaccine for Cancer Prevention$101,500
R03 · FY2008 · CA · contact PI
TESTING GHRELIN AND PYY VACCINES$55,151
P51 · FY2008 · RR · contact PI
GHRELIN VACCINES FOR CONTROLLING OBESITY$374,937
R44 · FY2007 · DK · contact PI
TESTING GHRELIN AND PYY VACCINES$103,634
P51 · FY2007 · RR · contact PI
GHRELIN VACCINES FOR CONTROLLING OBESITY$374,937
R44 · FY2006 · DK · contact PI
EPITOPE-SPECIFIC ANTIBODIES FOR ALZHEIMER'S DISEASE$132,413
R44 · FY2006 · AG · contact PI
TESTING GHRELIN AND PYY VACCINES$34,958
P51 · FY2006 · RR · contact PI
EPITOPE-SPECIFIC ANTIBODIES FOR ALZHEIMER'S DISEASE$374,937
R44 · FY2005 · AG
GHRELIN VACCINES FOR CONTROLLING OBESITY$74,098
R44 · FY2005 · DK
TESTING GHRELIN AND PYY VACCINES$52,759
P51 · FY2005 · RR
ALZHEIMER'S DISEASE VACCINE$33,521
P51 · FY2005 · RR
IMMUNOTHERAPEUTIC AGENTS TO TREAT ALZHEIMER'S DISEASE$420,400
R01 · FY2004 · AG
EPITOPE-SPECIFIC ANTIBODIES FOR ALZHEIMER'S DISEASE$374,937
R44 · FY2004 · AG
ALZHEIMER'S DISEASE VACCINE$35,475
P51 · FY2004 · RR
IMMUNOTHERAPEUTIC AGENTS TO TREAT ALZHEIMER'S DISEASE$420,400
R01 · FY2003 · AG
IMMUNOTHERAPY OF ALZHEIMER'S DISEASE$133,750
R44 · FY2003 · AG
EPITOPE-SPECIFIC ANTIBODIES FOR ALZHEIMER'S DISEASE$100,000
R44 · FY2003 · AG
ALZHEIMER'S DISEASE VACCINE$24,966
P51 · FY2003 · RR
IMMUNOTHERAPEUTIC AGENTS TO TREAT ALZHEIMER'S DISEASE$420,400
R01 · FY2002 · AG
IMMUNOTHERAPEUTIC AGENTS TO TREAT ALZHEIMER'S DISEASE$367,850
R01 · FY2001 · AG
IMMUNOTHERAPY OF ALZHEIMER'S DISEASE$348,695
R44 · FY2001 · AG
VACCINE TO ELICIT CATALYTIC ANTICOCAINE ANTIBODIES$169,200
R21 · FY2001 · DA
IMMUNOTHERAPY OF ALZHEIMER'S DISEASE$378,083
R44 · FY2000 · AG
IMMUNOTHERAPEUTIC AGENTS TO TREAT ALZHEIMER'S DISEASE$329,000
R01 · FY2000 · AG
VACCINE TO ELICIT CATALYTIC ANTICOCAINE ANTIBODIES$169,200
R21 · FY2000 · DA
BINARY SYSTEM FOR CELL TARGETED DELIVERY$131,600
R21 · FY2000 · GM